Photo for: Lexaria Bioscience: Medical Cannabinoid Researcher of Canada

Producer Profiles

Lexaria Bioscience: Medical Cannabinoid Researcher of Canada

Lexaria Bioscience Corp is the creator and licensor of revolutionary DehdraTECH Technology for lower overall dosing and higher effectiveness of drugs.

29/11/2018

Lexaria Bioscience Corp. developes and licences the most disruptive and cost effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules. It has acquired the precedent of the DehydraTECHTM technology in the year 2014 and since then it has strengthened and widened the technology into wider horizons. Thereby it has emerged as a global leader in enhancing the speed of action, flavour and gastro-intestinal delivery of orally administered products. DehydraTECH™ has been both laboratory and market proven to enhance the performance of beneficial compounds in ingestible products across four categories:

  • Taste
  • Smell
  • Speed of action
  • Bio-absorption & bio-availability

This ground breaking technology is protected by a robust suite of patents granted or pending worldwide and is proven effective in multiple international studies in greatly assisting rapidity and quantity of absorption of a range of lipophilic which is a fat-soluble, bioactive molecule.  By enhancing the performance and experience with oral ingestion, DehydraTECH™ delivery technology offers a viable and often healthier alternative to other delivery methods for bioactive substances in widespread use today such as inhalational delivery through smoking.

DehydraTECH™ was designed to be effective in delivering most fat-soluble molecules through the human gastrointestinal system and has also demonstrated affinity for transdermal applications and even effectiveness in crossing the blood-brain-barrier once within blood plasma. DehydraTECH™ can be used to improve existing products or to create new products. It is suitable for use with a wide range of consumer product formats including:

  • Processed foods
  • Beverages
  • Capsules
  • Oral Sprays
  • Topical Applications

In 2018, Lexaria Bioscience Technology created various different wholly-owned subsidiary companies to each focus on commercial opportunities in their respective industries:

Together, all the subsidiaries are empowered with global exclusive licenses to utilize and sub-license the DehydraTECH Technology.

Lexaria is proud of its talented and dedicated resources that helped in developing this revolutionary technology and expanding it.  Lexaria has a wide range of eminent personalities for internal and consulting team which consists industry leaders, research scientists, clinicians, analytical chemists, medical schools and universities, intellectual property experts and partnering company collaborators.